Search results
Wall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a...
Zacks via Yahoo Finance· 3 hours agoThe average of price targets set by Wall Street analysts indicates a potential upside of 188.7% in...
Deep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings) - Vir Biotechnology...
Benzinga· 4 hours agoLoading... Loading... Across the recent three months, 6 analysts have shared their insights on Vir Biotechnology VIR , expressing a variety of opinions spanning from bullish ...
Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with...
WRBL Columbus· 3 hours agoCellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based private biotechnology ...
FDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use...
Benzinga· 25 minutes agoIncannex Healthcare Inc. IXHL, a cannabinoid and psychedelic medicine biotechnology company,...
How quantum physics could 'revolutionise everything'
BBC via Yahoo News· 4 hours agoLiam Hall's career has taken him from diesel mechanic to quantumbiotechnology [CSIRO] Growing up on a farm in Australia, Liam Hall was a mechanic...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 6 hours agoIndustry Description The Zacks Biomedical and Genetics industry includes biopharmaceutical and ...
Earnings call: Puma Biotechnology reports Q1 2024 results, NERLYNX sales dip By Investing.com
Investing.com· 4 days agoPuma Biotechnology, Inc. (NASDAQ:PBYI) discussed its first-quarter financial results for 2024,...
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
NewMediaWire via Yahoo Finance· 4 hours agoGeoVax to Host Conference Call at 4:30 PM ET ATLANTA, GA - (NewMediaWire) - May 07, 2024 - GeoVax...
Lithuanian Biotech Pioneer 'Nando' Embarks on Global Expansion With New Management Team and...
Digital Journal· 11 hours agoPRESS RELEASE Published May 7, 2024 ACCESSWIRE "Nando", a leading Lithuanian-owned biotechnology company known for its groundbreaking work in developing microbiological products ...
GlycoMimetics reports data from Phase III AML treatment trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoUS-based biotechnology company GlycoMimetics has released topline results from its Phase III...